您的位置: 专家智库 > >

国家自然科学基金(20601010)

作品数:4 被引量:23H指数:2
相关作者:李光华施展冯守华毕明辉高路更多>>
相关机构:吉林大学清华大学更多>>
发文基金:国家自然科学基金北京市自然科学基金国家高技术研究发展计划更多>>
相关领域:理学更多>>

文献类型

  • 4篇中文期刊文章

领域

  • 4篇理学

主题

  • 1篇碘化
  • 1篇碘化亚铜
  • 1篇原位
  • 1篇原位合成
  • 1篇溶剂
  • 1篇溶剂热
  • 1篇铜配位聚合物
  • 1篇配位
  • 1篇配位聚合
  • 1篇配位聚合物
  • 1篇金属
  • 1篇金属铜
  • 1篇合成与结构表...
  • 1篇STRUCT...
  • 1篇TWO-DI...
  • 1篇UNITS
  • 1篇BENZOI...
  • 1篇BIO
  • 1篇CU
  • 1篇DRUG

机构

  • 2篇吉林大学
  • 1篇清华大学

作者

  • 2篇毕明辉
  • 2篇冯守华
  • 2篇施展
  • 2篇李光华
  • 1篇宁德宽
  • 1篇胡亚微
  • 1篇刘国宗
  • 1篇刘晓敏
  • 1篇高路

传媒

  • 2篇高等学校化学...
  • 1篇Chemic...
  • 1篇Scienc...

年份

  • 1篇2019
  • 3篇2009
4 条 记 录,以下是 1-4
排序方式:
Hydrothermal Synthesis and Structural Characterization of Three-dimensional Metal-organic Framework [Zn_3(C_2H_2N_3)_2(C_7H_5O_2)_4]
2009年
Hydrothermal reaction between mixed ligand(1,2,4-triazole and benzoic acid) and Zn(NO3)2·6H2O afforded a three-dimensional(3D) metal-organic framework Zn3(C2H2N3)2(C7H5O2)4(C2H2N3=1,2,4-triazole, C7H5O2=benzoic acid). The compound was crystallized in the hexagonal system with space group R3: a=2.90234(9) nm, b=2.90234(9) nm, c=1.08597(5) nm, γ=120°, V=7.9222(5) nm^3, Mr=816.68, Dc=1.541 g/cm^3, Z=9, F(000)=3708, R=0.0636, and wR=0. 1777. Its structure consists of ZnN2O2 tetrahedron and ZnN204 octahedron, which are connected by 1,2,4-triazole and benzoic acid ligands to form a 3D framework with helical units. This compound forms an interpenetrated NbO topology. The compound was characterized by single-crystal X-ray diffraction, elemental analysis, FTIR spectra, and TGA measurements.
SONG Zhe LI Guang-hua YU Yang SHI Zhan FENG Shou-hua
关键词:1,2,4-TRIAZOLE
两个金属铜配位聚合物Cu_3(2,2′-bipy)_2(C_8H_4O_4)_2(C_8H_5O_4)_2和Cu(Ⅰ)Cu(Ⅱ)(4,4′-bipy)_(1.5)(C_8H_4O_4)(C_8H_5O_4)混合溶剂热合成及结构与性能研究被引量:8
2009年
在中温混合溶剂热条件下合成了两个金属铜配位聚合物Cu3(2,2′-bipy)2(C8H4O4)2(C8H5O4)2和Cu(Ⅰ)Cu(Ⅱ)(4,4′-bipy)1.5(C8H4O4)(C8H5O4)(bipy=联吡啶,C8H4O4=1,3-间苯二甲酸),并对其进行了单晶结构解析及相关性能表征.配合物Cu3(2,2′-bipy)2(C8H4O4)2(C8H5O4)2(1)晶体属三斜晶系,P1空间群,a=1.03314(4)nm,b=1.08350(3)nm,c=1.15826(4)nm,α=83.104(2)°,β=84.609(2)°,γ=66.125(2)°,Z=1.配合物Cu(Ⅰ)Cu(Ⅱ)(4,4′-bipy)1.5(C8H4O4)(C8H5O4)(2)晶体属三斜晶系,P1空间群,a=1.06979(3)nm,b=1.09209(3)nm,c=1.47887(3)nm,α=91.795(2)°,β=93.2460(10)°,γ=118.6170(10)°,Z=2.通过使用不同的有机碱配体(2,2′-联吡啶和4,4′-联吡啶),并调节不同有机碱配体的用量,得到了结构不同的两个目标晶体产物相.产物均可稳定到300℃.
高路李光华毕明辉胡亚微刘晓敏施展冯守华
关键词:铜配位聚合物
Two-dimensional nanomaterials: fascinating materials in biomedical field被引量:14
2019年
Due to their high anisotropy and chemical functions,two-dimensional(2D)nanomaterials have attracted increasing interest and attention from various scientific fields,including functional electronics,catalysis,supercapacitors,batteries and energy materials.In the biomedical field,2D nanomaterials have made significant contributions to the field of nanomedicine,especially in drug/gene delivery systems,multimodal imaging,biosensing,antimicrobial agents and tissue engineering.2D nanomaterials such as graphene/graphene oxide(GO)/reduced graphene oxide(r GO),silicate clays,layered double hydroxides(LDHs),transition metal dichalcogenides(TMDs),transition metal oxides(TMOs),black phosphorus(BP),graphitic carbon nitride(g-C3N4),hexagonal boron nitride(h-BN),antimonene(AM),boron nanosheets(B NSs)and tin telluride nanosheets(Sn Te NSs)possess excellent physical,chemical,optical and biological properties due to their uniform shapes,high surface-to-volume ratios and surface charge.In this review,we first introduce the properties,structures and synthetic strategies of different configurations of 2D nanomaterials.Recent advances and paradigms of 2D nanomaterials in a variety of biomedical applications,ranging from drug delivery,cancer treatment,bioimaging and tissue engineering to biosensing are discussed afterwards.In the final part,we foresee the development prospects and challenges of 2D nanomaterials after summarizing the research status of ultrathin 2D nanomaterials.
Tingting HuXuan MeiYingjie WangXisheng WengRuizheng LiangMin Wei
关键词:NANOMATERIALSDRUGTISSUEBIOSENSING
(C6H8N3)^+I3^-和[(Cu3I4)(C8H17N2)]配体原位合成与结构表征被引量:1
2009年
在溶剂热条件下,以原位反应为基础合成了两个碘化物(C6H8N3)+I3-(1,C6H8N3=2,3-dihydroimi-dazo[1,2-a]pyrimidin-1-ium,2,3-二氢咪唑[1,2-α]-嘧啶鎓阳离子)和[(Cu3I4)(C8H17N2)](2,C8H17N2=N-ethyl-4-aza-1-azonia-bicyclo[2.2.2]octane,N-乙基三乙烯二铵阳离子).用元素分析、粉末X射线衍射及单晶X射线衍射等对化合物进行了表征.结果表明,化合物1属于三斜晶系,P1空间群,a=0.74281(15)nm,b=0.84241(17)nm,c=0.9993(2)nm,α=82.02(3)°,β=83.30(3)°,γ=82.92(3)°,V=0.6114(2)nm3.化合物2属于单斜晶系,P21/c空间群,a=0.68924(14)nm,b=1.0786(2)nm,c=2.2779(5)nm,β=94.84(3)°,V=1.6874(6)nm3.在两个化合物合成中存在两种不同类型的配体原位合成反应,即化合物1的2-氨基嘧啶和乙醇的成环反应与化合物2的三乙烯二胺和乙醇的烷基化反应.
宁德宽毕明辉李光华刘国宗施展冯守华
关键词:溶剂热原位合成碘化亚铜
共1页<1>
聚类工具0